Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.58 |
| ▸ | HPGD | P15428 | 6/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9036274 | 0.86 | LIG1 (0.61) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL598345 | 0.85 | MEN1 (0.69) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL31211720 | 0.85 | CYP19A1 (0.66) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL1878649 | 0.84 | TERT (0.52) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL7826271 | 0.83 | KDM4E (0.56) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL1701142 | 0.81 | PTPN1 (0.57) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL19809218 | 0.81 | KDM4E (0.54) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL6129338 | 0.81 | KDM4E (0.54) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL12302413 | 0.81 | KDM4E (0.54) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 | |
| SCHEMBL7819309 | 0.81 | HPGD (0.55) | KDM4EHPGDALDH1A1SMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055051-A1 | Compound with anti-tumor activity, preparation method therefor, and use thereof | OCEAN UNIV CHINA (CN) | 2026-02-26 | — | — | US | claimed |
| US-20250231190-A1 | ENHANCED FLUORESCENCE SIGNAL THROUGH THE APPLICATION OF AROMATIC ADDITIVES ONTO THE MICROSCOPY SAMPLE FOR STANDARD FLUORESCENCE, FLUORESCENCE MICROSCOPY AND COMBINED FLUORESCENCE MALDI MICROSCOPY/IMAGING | THE JOHNS HOPKINS UNIVERSITY | 2025-07-17 | — | — | US | claimed |
| WO-2025092541-A1 | LITHIUM EXTRACTION RESIN STRUCTURE, PREPARATION, AND USE | 北京索特莱克科技发展有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-221016077-U | 2,6 Dihydroxy acetophenone acylation reaction system | 曲靖常宜联合科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-221016054-U | 2,6 Dihydroxyacetophenone hydrolysis reaction device | 曲靖常宜联合科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2024031970-A1 | COMPOUND WITH ANTI-TUMOR ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国海洋大学 | 2024-02-15 | — | — | WO | claimed |
| US-20240003899-A1 | METHOD FOR DETECTION OF ANALYTES IN A SINGLE TISSUE SAMPLE FROM ITO SLIDES USING MSI-LCM | ACADEMISCH ZIEKENHUIS MAASTRICHT (NL) | 2024-01-04 | — | — | US | claimed |
| CN-115427514-B | Resin composition, light-shielding film, and substrate with partition wall | 东丽株式会社 | 2024-01-02 | — | — | CN | claimed |
| US-11827605-B2 | Isoquinoline compounds and their use in treating AhR imbalance | Dermavant Sciences GmbH (CH) | 2023-11-28 | — | — | US | claimed |
| CN-116655577-B | Flavone derivative aminopeptidase N inhibitor and preparation method and application thereof | 山东中医药大学 | 2023-11-14 | — | — | CN | claimed |
| WO-2003030845-A1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-04-17 | — | — | WO | claimed |
| WO-2003030842-A1 | AGENT FOR COLOURING FIBRES CONTAINING KERATIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-04-17 | — | — | WO | claimed |
| EP-1300133-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| EP-1300132-A2 | Agent for dyeing keratinous fibres | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-04-09 | — | — | EP | claimed |
| WO-1996022077-A1 | ARYL KETONES FOR COLOURING KERATIN-CONTAINING FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-07-25 | — | — | WO | claimed |
| US-5508451-A | Process for the preparation of dialkali metal cromoglycates | HOECHST CELANESE CORPORATION (US) | 1996-04-16 | — | — | US | claimed |
| US-5506348-A | COMPOSITION CONTAINING AMMONIUM SALT OF ORGANIC OR INORGANIC ACID, HYDROXY SUBSTITUTED PHENONE, HIGH MOLECULAR WEIGHT COMPOUND | CIBA-GEIGY CORPORATION (US) | 1996-04-09 | — | — | US | claimed |
| EP-0498707-B1 | Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent | OREAL (FR) | 1995-08-02 | — | — | EP | claimed |
| EP-0612994-A2 | Matrix for matrix-assisted laser desorption mass spectroscopy | CIBA-GEIGY AG (CH) | 1994-08-31 | — | — | EP | claimed |
| EP-0498707-A1 | Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent | L'OREAL (FR) | 1992-08-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055051-A1 | Compound with anti-tumor activity, preparation method therefor, and use thereof | RCC2, WEE2, MET | KDM4E 657/4885HPGD 2452/4885ALDH1A1 838/4885 |
| US-11827605-B2 | Isoquinoline compounds and their use in treating AhR imbalance | AHR, ARNT, HRH1 | KDM4E 2743/4885HPGD 123/4885ALDH1A1 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.